David Dodwell

BSc, MD, FRCP, FRCR

Senior Clinical Research Fellow

I am a senior breast oncologist based in Leeds with a number of research and governance activities. I am the lead oncologist on the Sloane, NHS screening & national HQIP breast cancer audits.

I am a senior clinical research fellow to the EBCTCG and a member of steering groups for 12 ongoing UK trials in breast cancer. I sit on the trial management committees for 3 trials.

I am UK lead for the SACT project (UK chemotherapy database) and chair the clinical group, which provides input and advice to this project to examine the safety, efficacy and cost-effectiveness of chemotherapy used in England.

Recent publications

Endocrine therapy in the years following a diagnosis of breast cancer: A proof of concept study using the primary care prescription database linked to cancer registration data.
Journal article

Emanuel G. et al, (2019), Cancer Epidemiol, 61, 185 - 189
International Variation in Criteria for Internal Mammary Chain Radiotherapy.
Journal article

Duane FK. et al, (2019), Clin Oncol (R Coll Radiol)
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Journal article

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452
Adjuvant treatment for breast cancer
Journal article

Flatley MJ. and Dodwell DJ., (2019), Surgery (United Kingdom), 37, 176 - 180
The SMALL Trial: A Big Change for Small Breast Cancers
Journal article

Morgan J. et al, (2019), Clinical Oncology

More publications